Web282 rows · Jan 13, 2024 · Granules Pharmaceuticals: Metformin HCl 750 mg Extended … WebJul 8, 2024 · Granules India Ltd. is voluntarily recalling 12 lots of its type 2 diabetes drug metformin hydrochloride in the U.S. after detecting a potentially cancer-causing impurity. The recall was issued due to the presence of higher than acceptable daily intake levels of an impurity called N-Nitrosodimethylamine, or NDMA, Granules said in a company ...
Diabetes Drug, Metformin, Recalled for Cancer-Causing Contamination
WebJun 25, 2024 · Marksans Pharma / Time-Cap Labs, Teva/Actavis, Apotex, Amneal Pharmaceuticals LLC. Manufacturers, Major Pharmaceuticals, Granules Pharmaceuticals Inc, and Lupin Pharmaceuticals Inc. If you filled Metformin extended-release tablets 500mg, 750mg or 1,000mg at a RETAIL or MTF pharmacy, please … WebJul 15, 2024 · By Nena Kotsalidis and Rosalind Lucier. The FDA has announced that 14 companies have voluntarily recalled their extended release metformin due to the possibility that it includes unsafe levels of NDMA, a toxic substance. Editor's note: This article was first published on July 15, 2024 and has since been updated to reflect the latest recalls. dichotomous logic
RETAIL and/or MTF Pharmacy - Metformin Extended-Release Tablets Recall ...
WebJul 13, 2024 · Another pharma maker recalls metformin over NDMA. July 13, 2024. Christine Blank. ... levels above the acceptable daily limit, another manufacturer is recalling certain lots of metformin. Granules Pharmaceuticals is voluntarily recalling 12 lots of its Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100-count, and 500 … WebJul 7, 2024 · Major Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. This lot (Lot#: T-02134, … WebOct 9, 2024 · A widely-used diabetes drug has been recalled after manufacturers found it contained unacceptably high levels of a cancer-causing contaminant.. Indian … citizen home loans phone